Frontlight ResearchEarly access
Colorectal cancer trials in United States
551 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 1/2Taking peopleStudy of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
- Where
- Aurora, Boston, Dallas, Detroit, Duarte, Fairfax, Grand Rapids, Houston, Indianapolis, Irving, Nashville, New York, Oklahoma City, Orange, Pittsburgh, Sacramento, San Antonio, Sarasota, Stanford, Tampa
- Age
- 18 years and over
- People
- 534 worldwide
- Run by
- Revolution Medicines, Inc.
See details and how to joinNCT06128551 - Phase 1/2Taking peopleStudy of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
- Where
- Aurora, Baltimore, Boston, Chandler, Cincinnati, Durham, Fairfax, Houston, Irving, Jacksonville, La Jolla, Lake Success, Los Angeles, Morristown, Nashville, New Haven, New York, Oklahoma City, Omaha, Philadelphia, Phoenix, Rochester, Salt Lake City, Scottsdale, Seattle, Tampa, Westwood
- Age
- 18 years and over
- People
- 1,130
- Run by
- Revolution Medicines, Inc.
See details and how to joinNCT06445062 - Phase 2Taking peopleA Study of Botensilimab and Balstilimab for Colorectal Cancer With ctDNA+ After Surgery and Chemotherapy
- Where
- Basking Ridge, Commack, Harrison, Middletown, Montvale, New York, Rockville Centre
- Age
- 18 years and over
- People
- 284
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT07227636 - Phase 1/2Taking peopleManipulation of the Gut Microbiome by a Standardized Preoperative Diet to Prevent Colorectal Cancer Recurrence and Metastasis Following Surgery
- Where
- Chicago
- Age
- 18 years and over
- People
- 80
- Run by
- University of Chicago
See details and how to joinNCT06349590 - Phase 1/2Taking peopleA First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
- Where
- Ann Arbor, Baton Rouge, Boston, Fairfax, Hackensack, Houston, Nashville, New York, Sarasota, Tampa
- Age
- 18 years and over
- People
- 265 worldwide
- Run by
- Blueprint Medicines Corporation
See details and how to joinNCT07629960 - No phaseTaking peoplePrehabilitation in High-risk Oncologic Surgery
- Where
- Philadelphia
- Age
- 18 years and over
- People
- 180
- Run by
- Fox Chase Cancer Center
See details and how to joinNCT07638410 - No phaseEnrolling by invitationDevelopment and Analysis of a Stool Bank for Cancer Patients
- Where
- Fountain Valley, Winter Haven
- Age
- 18 years and over
- People
- 100
- Run by
- Persephone Biosciences
See details and how to joinNCT04291755 - Phase 1Taking peopleStudy of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
- Where
- Baltimore, Boston, Dallas, Fairfax, Grand Rapids, New Haven, New York, San Antonio
- Age
- 18 years and over
- People
- 574
- Run by
- Revolution Medicines, Inc.
See details and how to joinNCT07349537 - No phaseTaking peopleEstablishing a ctDNA Biomarker to Improve Organ Preserving Strategies in Patients With Rectal Cancer
- Where
- Portland, Seattle
- Age
- 18 years and over
- People
- 50
- Run by
- OHSU Knight Cancer Institute
See details and how to joinNCT05081024 - No phaseTaking peopleMultilevel Action Toward Colorectal Cancer and Hepatitis C Education and Screening
- Where
- Tampa
- Age
- 45 years to 75 years
- People
- 350
- Run by
- H. Lee Moffitt Cancer Center and Research Institute
See details and how to joinNCT06745895 - Phase 1Taking peopleSafety and Efficacy of PIPAC Using Single Agent Mitomycin in Solid Tumors
- Where
- Tampa
- Age
- 18 years and over
- People
- 24
- Run by
- H. Lee Moffitt Cancer Center and Research Institute
See details and how to joinNCT07487168 - Phase 2Taking peopleLiposomal Irinotecan With TAS102 and Bevacizumab for Patients With Metastatic Colorectal Cancer
- Where
- Madison
- Age
- 18 years and over
- People
- 50
- Run by
- University of Wisconsin, Madison
See details and how to joinNCT05854498 - No phaseTaking peopleEQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer.
- Where
- Cleveland
- Age
- 18 years and over
- People
- 200
- Run by
- Case Comprehensive Cancer Center
See details and how to joinNCT06263088 - Phase 1/2Not yet taking people in United StatesA Study of IOV-5001 in Adults With Advanced Solid Tumors
- Where
- New York
- Age
- 18 years to 70 years
- People
- 106
- Run by
- Iovance Biotherapeutics, Inc.
See details and how to joinNCT07743723 - No phaseTaking peopleORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- Where
- Appleton, Aurora, Birmingham, Boston, Broomall, Chandler, Chapel Hill, Cincinnati, Cleveland, Dallas, East Brunswick, Edinburg, Forth Worth, Grand Rapids, Hollywood, Hot Springs, La Jolla, Lakeland, Lewiston, Myrtle Beach, New Orleans, Newport Beach, New York, Philadelphia, Redwood City, Rochester, Rock Hill, Sacramento, Salt Lake City, San Antonio, Shreveport, Toledo, York
- Age
- 18 years and over
- People
- 2,285 worldwide
- Run by
- Guardant Health, Inc.
See details and how to joinNCT05059444 - Phase 2Taking peopleAn Investigational Drug (TPST-1495) in Patients With Familial Adenomatous Polyposis
- Where
- Madison, Phoenix, Rochester, Salt Lake City
- Age
- 18 years and over
- People
- 38
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT06557733 - Phase 1/2Taking peopleSafety of HRX215 in Patients After Minor and Major Liver Resection
- Where
- Baltimore, Cleveland, Durham, Rochester
- Age
- 18 years to 75 years
- People
- 80 worldwide
- Run by
- HepaRegeniX GmbH
See details and how to joinNCT06638502 - No phaseTaking peopleTier Palliative Care For Patients With Advanced Heart Failure or Cancer
- Where
- Astoria, New York
- Age
- 18 years and over
- People
- 400
- Run by
- Icahn School of Medicine at Mount Sinai
See details and how to joinNCT07391956 - No phaseTaking peopleSIBYL: obServation of Therapy Response With lIquid BiopsY evaLuation
- Where
- Skokie
- Age
- 18 years and over
- People
- 470
- Run by
- Guardant Health, Inc.
See details and how to joinNCT05935384 - Phase 1Taking peopleOpen-label Phase 1b Study of Ulixertinib and Cetuximab or Ulixertinib in Combination With Cetuximab and Encorafenib in Patients With Unresectable or Metastatic Colorectal Cancer Who Have Previously Received EGFR or BRAF-directed Therapy
- Where
- Houston
- Age
- 18 years and over
- People
- 27
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT05985954 - No phaseTaking peopleExercise for Gut Microbiome in Patients With Young-Onset Colorectal Cancer Undergoing Chemotherapy: The COURAGE Trial
- Where
- Boston
- Age
- 18 years to 50 years
- People
- 84
- Run by
- Dana-Farber Cancer Institute
See details and how to joinNCT06202183 - No phaseNot yet taking people in United StatesA Preregistered Multi-Cohort Evaluation of the FATHOM AI System for Molecular Testing Prioritization to Support Clinical Trial Enrollment
- Where
- Boston
- People
- 30,000
- Run by
- Harvard Medical School (HMS and HSDM)
See details and how to joinNCT07814872 - No phaseTaking peopleResilience and Equity in Aging, Cancer, and Health (REACH)
- Where
- Boston
- Age
- 65 years and over
- People
- 147
- Run by
- Dana-Farber Cancer Institute
See details and how to joinNCT04674267 - Phase 1Taking peopleSKL35501 With SKL35502 Imaging in Adults With NTSR1 Positive Advanced Solid Tumors
- Where
- Glen Burnie, Pittsburgh
- Age
- 18 years and over
- People
- 100 worldwide
- Run by
- SK Life Science, Inc.
See details and how to joinNCT07812805 - Phase 2Taking peopleStereotactic Brain-directed Radiation With or Without Aguix Gadolinium-Based Nanoparticles in Brain Metastases
- Where
- Boston
- Age
- 18 years and over
- People
- 134
- Run by
- Brigham and Women's Hospital
See details and how to joinNCT04899908